SCHEMBL6993983

SCHEMBL6993983

COC(=O)c1n[nH]c(C(=O)O)c1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.56
KDM4E B2RXH2 2/20 0.42
STAT3 P40763 1/20 0.42
HIF1A Q16665 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 4/20 0.40
LMNA P02545 2/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 2/20 0.36
TP53 P04637 1/20 0.36
HCAR2 Q8TDS4 3/20 0.34
GAA P10253 1/20 0.34
FLT3 P36888 1/20 0.34
PRKAG1 P54619 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993979 0.89 KDM4C (0.65) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL1009945 0.79 KDM4C (0.52) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL7377130 0.79 PRKAG1 (0.47) KDM4ENPSR1ALDH1A1LMNASMN1; SMN2
SCHEMBL27128818 0.79 KDM4C (0.56) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL16919030 0.76 KDM4C (0.62) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL28542157 0.76 KDM4C (0.53) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL28954025 0.76 KDM4C (0.53) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL7254882 0.76 KDM4C (0.53) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL7378141 0.76 KDM4C (0.45) KDM4CKDM4ESTAT3HIF1ANPSR1
SCHEMBL4038517 0.75 KDM4C (0.56) KDM4CKDM4ESTAT3HIF1ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123296-B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LTD (GB) 2003-09-17 EP disclosed
US-6333330-B1 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-12-25 US disclosed
EP-1123296-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2001-08-16 EP disclosed
WO-2000024745-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 2000-05-04 WO disclosed